Monitoring neuroprotection and restorative therapies in Parkinson’s disease with PET
Publisher
Springer Vienna
Reference40 articles.
1. Alexander T, Sortwell CE, Sladek CD, Roth RH, Steece-Collier K (1997) Comparison of neurotoxicity following repeated administration of L-dopa, D-dopa, and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fischer 344 and Sprague-Dawley donors. Cell Transplant 6: 309-315
2. Banati RB, Goerres GW, Brooks DJ et al (1999a) PK11195 positron emission tomography imaging of activated microglia in Rasmussen’s encephalitis. Neurology 53: 2199-2203
3. Parkinsonism Relat Disord;R Banati,1999
4. Brundin P, Pogarel O, Hagell P et al (2000) Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson’s disease. Brain (in press)
5. Ellias SA, Palmer EP, Kott HS et al (1998) Transplantation of fetal porcine ventral mesencephalic cells for treatment of Parkinson’s disease: One year safety and efficacy results. Neurology 50 Suppl 4: A80